EPRX Earnings
Eupraxia Pharmaceuticals Inc.
1W: -9.6%
1M: -2.8%
3M: +11.0%
YTD: -4.4%
1Y: +19.3%
$7.24
-0.59 (-7.54%)
Weekly Expected Move ±12.5%
$5
$6
$7
$8
$9
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-08-11
EPS
C$-0.16 (US$-0.11)
▲ Beat +30.6%
Revenue
—
Next Earnings
2026-11-03
EPS Estimate
C$-0.41 (US$-0.29)
Range: C$-0.53 - C$-0.34
1 USD = 1.43 CAD
Estimate vs Actual
Earnings Surprise History
2/14
EPS Beats
0/14
Revenue Beats
14%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | quarter | 2026-09-30 | C$-0.38 | C$-0.38 | — | C$— | C$— |
| 2026-10-02 | quarter | 2026-12-30 | C$-0.41 | C$-0.41 | — | C$— | C$— |
| 2026-10-02 | annual | 2030-12-31 | C$-1.26 | C$-1.26 | — | C$— | C$— |
| 2026-10-02 | quarter | 2029-12-30 | C$-0.60 | C$-0.60 | — | C$— | C$— |
| 2026-10-02 | quarter | 2029-09-30 | C$-0.59 | C$-0.59 | — | C$— | C$— |
| 2026-10-02 | quarter | 2027-09-30 | C$-0.38 | C$-0.38 | — | C$— | C$— |
| 2026-10-02 | quarter | 2029-06-30 | C$-0.61 | C$-0.61 | — | C$— | C$— |
| 2026-10-02 | annual | 2026-12-31 | C$-1.25 | C$-1.25 | — | C$— | C$— |
| 2026-10-02 | quarter | 2028-09-30 | C$-0.46 | C$-0.46 | — | C$— | C$— |
| 2026-10-02 | annual | 2029-12-31 | C$-1.89 | C$-1.91 | ▼ 0.02 | C$— | C$— |
| 2026-10-02 | quarter | 2027-06-30 | C$-0.37 | C$-0.37 | — | C$— | C$— |
| 2026-10-02 | quarter | 2027-03-30 | C$-0.36 | C$-0.36 | — | C$— | C$— |
| 2026-10-02 | quarter | 2028-03-30 | C$-0.35 | C$-0.35 | — | C$— | C$— |
| 2026-10-02 | quarter | 2028-06-30 | C$-0.40 | C$-0.40 | — | C$— | C$— |
| 2026-10-02 | quarter | 2027-12-30 | C$-0.40 | C$-0.40 | — | C$— | C$— |
Earnings Call Transcripts
No transcripts available.